Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

Condition:   Neurofibromatosis 1 Interventions:   Drug: N-Acetyl cysteine;   Other: Placebo Sponsors:   Children's Hospital Medical Center, Cincinnati;   United States Department of Defense Not yet recruiting

Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials